Jul 27, 2020
F. Hoffmann-La Roche Announces Half Year Results 2020
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| Chairman & CEO: | Tatsuro Kosaka |
| Inquiries to: | Masahiko Uchida |
| Head of Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its half year results 2020 (January 1 – June 30, 2020) on July 23, 2020 (local time).
Roche owns 59.89% of Chugai’s outstanding shares (61.18% of the total number of shares issued excluding treasury stock) as of the end of June 2020.
The press release and presentation materials can be found on its website (https://www.roche.com).
Chugai’s performance for the period of January 1 to June 30, 2020 is included in the announced Roche Group’s results.
| Investor Updates | Presentations | Half-Year Report 2020 |
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Tomoko Shimizu
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
